Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus

OBJECTIVE: The American Academy of Ophthalmology recommends a maximum hydroxychloroquine (HCQ) dose of ≤5.0 mg/kg/day to reduce the risk of HCQ-induced retinopathy. To determine if this dose adjustment would have an impact on the clinical course of SLE, we compared outcome measures in a cohort of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Otero, Ileana, Medina-Cintrón, Nicolle, Arroyo-Ávila, Mariangelí, González-Sepúlveda, Lorena, Vilá, Luis M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Epidemiology and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245425/
https://www.ncbi.nlm.nih.gov/pubmed/32434863
http://dx.doi.org/10.1136/lupus-2020-000395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245425/
https://www.ncbi.nlm.nih.gov/pubmed/32434863
http://dx.doi.org/10.1136/lupus-2020-000395

Ejemplares similares